Correct Answer: D. Minimal Change Disease (MCD)
Effacement (fusion) of podocyte foot processes is the pathognomonic ultrastructural finding in Minimal Change Disease (MCD), visible only on electron microscopy. This is the defining lesion that distinguishes MCD from other glomerulonephritides. In MCD, the glomeruli appear completely normal on light microscopy (hence "minimal change"), but electron microscopy reveals widespread foot process effacement affecting >50% of the glomerular basement membrane surface. This effacement is reversible and correlates with proteinuria—as foot processes fuse, the filtration barrier becomes permeable to albumin, causing nephrotic-range proteinuria (typically >3.5 g/day). MCD accounts for 85–90% of nephrotic syndrome in Indian children and 10–15% in adults. The mechanism involves loss of the slit diaphragm architecture (podocin, nephrin, CD2AP dysfunction), though the exact trigger remains unclear. Crucially, foot process effacement is NOT seen in chronic glomerulonephritis (CGN), rapidly progressive glomerulonephritis (RPGN), or steroid-resistant GN—these show distinct light microscopic changes (sclerosis, crescent formation, proliferation) and different electron microscopic patterns. MCD responds dramatically to corticosteroids in 90% of cases, making early recognition critical for Indian pediatric nephrology practice.
Why the other options are wrong
A. Chronic glomerulonephritis — CGN shows light microscopic changes (sclerosis, hyalinization, crescent formation) and electron microscopy reveals thickened basement membrane, electron-dense deposits, or segmental sclerosis—not foot process effacement. CGN is a chronic, progressive lesion with irreversible renal damage, whereas MCD is reversible. This option exploits confusion between chronic and acute glomerular pathology. B. Rapidly progressive glomerulonephritis — RPGN is characterized by crescent formation on light microscopy (fibrocellular or fibrinous crescents) and rapid loss of renal function. Electron microscopy shows variable findings depending on the type (anti-GBM, ANCA, immune complex), but foot process effacement is not the defining feature. RPGN presents with hematuria and dysmorphic RBCs, not pure nephrotic syndrome like MCD. C. Steroid-resistant glomerulonephritis — Steroid-resistant GN encompasses focal segmental glomerulosclerosis (FSGS), IgA nephropathy, and membranoproliferative GN—all showing segmental sclerosis, proliferation, or deposits on electron microscopy. While FSGS may show partial foot process effacement in non-sclerosed segments, the hallmark is segmental sclerosis, not diffuse foot process effacement. This option conflates steroid resistance with the ultrastructural hallmark of MCD.
High-Yield Facts
- Foot process effacement is pathognomonic for MCD and visible only on electron microscopy; light microscopy is normal.
- MCD accounts for 85–90% of nephrotic syndrome in Indian children and 10–15% in adults; presents with nephrotic-range proteinuria (>3.5 g/day) and selective proteinuria.
- Corticosteroid response rate is 90% in MCD; relapse occurs in 30–40% of cases, making repeat steroid courses standard in Indian pediatric practice.
- Slit diaphragm proteins (nephrin, podocin, CD2AP) are disrupted in MCD, causing loss of charge and size selectivity of the filtration barrier.
- Light microscopy is normal in MCD—this absence of visible changes on routine microscopy is the key discriminator from RPGN (crescents), CGN (sclerosis), and FSGS (segmental sclerosis).
Mnemonics
MCD = Minimal on Light, Massive on Electron Minimal change on light microscopy (normal glomeruli) but Massive foot process effacement on electron microscopy. Use this to remember that MCD is a disease of ultrastructure, not visible pathology. FSGS vs MCD: Sclerosis is the Difference Focal Segmental GlomeruloSclerosis shows segmental sclerosis on light microscopy; MCD shows nothing. Both may have foot process effacement, but only FSGS has visible sclerosis—this is why FSGS is steroid-resistant and MCD is steroid-responsive.
NBE Trap
NBE pairs "foot process effacement" with steroid-resistant GN (Option C) to trap students who conflate foot process changes with steroid resistance; in reality, diffuse foot process effacement without sclerosis is the hallmark of steroid-responsive MCD, not steroid-resistant disease.
Clinical Pearl
In Indian pediatric nephrology, a child presenting with nephrotic syndrome, normal renal function, and normal light microscopy on kidney biopsy is presumed to have MCD and started on steroids immediately—electron microscopy confirmation of foot process effacement is often deferred because early steroid response is diagnostic and therapeutic. This pragmatic approach has reduced unnecessary delays in Indian tertiary centers.
_Reference: Robbins & Cotran Pathologic Basis of Disease, Ch. 20 (Kidney); Harrison's Principles of Internal Medicine, Ch. 279 (Glomerular Diseases)_